Many associations have been found between interferon lambda 3 rs12979860 polymorphism and various clinical outcomes as a control of the hepatitis C virus infection [30], myeloproliferative neoplasms, dengue virus in children and systemic lupus erythematosus [31]. This evidence concerns the gene IFNL3 and myeloproliferative disorder.